Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tectonic Therapeutic, Inc. - Common Stock (NQ:TECX)

22.57 +1.13 (+5.27%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 215,784
Open 21.59
Bid (Size) 21.40 (2)
Ask (Size) 23.00 (2)
Prev. Close 21.44
Today's Range 21.23 - 22.65
52wk Range 13.70 - 61.07
Shares Outstanding 44,105,078
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Tectonic Therapeutic Joins Russell 3000® Index
From Tectonic Therapeutic
Via GlobeNewswire
Tectonic Therapeutic Presents Complete Results for Positive Phase 1b Clinical Trial of TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF in Late-Breaking Presentation at ESC Heart Failure 2025
From Tectonic Therapeutic
Via GlobeNewswire

Performance

YTD
-50.6%
-50.6%
1 Month
+4.7%
+4.7%
3 Month
+25.8%
+25.8%
6 Month
-40.6%
-40.6%
1 Year
+35.6%
+35.6%

More News

Read More
Tectonic Therapeutic Announces First Quarter 2025 Financial Results and Recent Business Highlights
From Tectonic Therapeutic
Via GlobeNewswire
Tectonic Therapeutic To Present on May 15th, 2025 at the Bank of America Securities Health Care Conference
From Tectonic Therapeutic
Via GlobeNewswire
This Dycom Industries Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Via Benzinga
Tectonic Therapeutic to Present Phase 1b Data for TX45 at European Society of Cardiology Heart Failure 2025
From Tectonic Therapeutic
Via GlobeNewswire
Tectonic Therapeutic Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
From Tectonic Therapeutic
Via GlobeNewswire
Tectonic Therapeutic to Participate in March Investor Conferences
From Tectonic Therapeutic
Via GlobeNewswire
Tectonic Announces $185 Million Private Placement
From Tectonic Therapeutic
Via GlobeNewswire
Let's take a look at the stocks that are in motion in today's session.
Via Chartmill
Top stock movements in today's session.
Via Chartmill
Nasdaq Moves Lower; Meta Platforms Posts Strong Sales
Via Benzinga
There are notable gap-ups and gap-downs in today's session.
Via Chartmill
IBM Posts Upbeat Earnings, Joins Oshkosh, Las Vegas Sands, Nokia, Quest Diagnostics And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Dow Jumps Over 100 Points; Tesla Earnings Miss Views
Via Benzinga
Topics Earnings Stocks
Stay updated with the stocks that are on the move in today's pre-market session.
Via Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Tectonic Therapeutic Announces Positive Interim Data from Phase 1b Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF
From Tectonic Therapeutic
Via GlobeNewswire
Top movers analysis one hour before the close of the markets on 2025-01-28: top gainers and losers in today's session.
Via Chartmill
Tectonic Therapeutic to Host KOL Event on the Unmet Need in Group 2 PH-HFpEF and TX45 as a Potential Treatment on Thursday, December 12, 2024
From Tectonic Therapeutic
Via GlobeNewswire
Tectonic Therapeutic To Present on December 3rd, 2024 at the Piper Sandler Healthcare Conference
From Tectonic Therapeutic
Via GlobeNewswire
Tectonic Therapeutic Announces Positive Phase 1a Results in AHA 2024 Presentation for TX45, a Long-acting, Fc-Relaxin Fusion Protein
From Tectonic Therapeutic
Via GlobeNewswire
Tectonic Therapeutic Announces Third Quarter 2024 Financial Results and Recent Business Highlights
From Tectonic Therapeutic
Via GlobeNewswire
Tectonic Therapeutic to Present Phase 1a Data at AHA 2024
From Tectonic Therapeutic
Via GlobeNewswire
Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45
From Tectonic Therapeutic
Via GlobeNewswire

Frequently Asked Questions

Is Tectonic Therapeutic, Inc. - Common Stock publicly traded?
Yes, Tectonic Therapeutic, Inc. - Common Stock is publicly traded.
What exchange does Tectonic Therapeutic, Inc. - Common Stock trade on?
Tectonic Therapeutic, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Tectonic Therapeutic, Inc. - Common Stock?
The ticker symbol for Tectonic Therapeutic, Inc. - Common Stock is TECX on the Nasdaq Stock Market
What is the current price of Tectonic Therapeutic, Inc. - Common Stock?
The current price of Tectonic Therapeutic, Inc. - Common Stock is 22.57
When was Tectonic Therapeutic, Inc. - Common Stock last traded?
The last trade of Tectonic Therapeutic, Inc. - Common Stock was at 07/16/25 04:00 PM ET
What is the market capitalization of Tectonic Therapeutic, Inc. - Common Stock?
The market capitalization of Tectonic Therapeutic, Inc. - Common Stock is 995.45M
How many shares of Tectonic Therapeutic, Inc. - Common Stock are outstanding?
Tectonic Therapeutic, Inc. - Common Stock has 995M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.